首页 >
法规速递
-
Page: Outcomes of imposed non-interventional post-authorisation safety studies-2025/12/2
2025-12-03查看详情 > -
Document: PRAC recommendations on signals adopted at the 24-27 November 2025 PRAC meeting-2026/1/6
2026-01-07查看详情 > -
Document: Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)-2026/2/10
2026-02-11查看详情 > -
Document: Timetable: Safety signal - Assessment of responses to request for supplementary information (RSI)-2026/3/19
2026-03-20查看详情 > -
国家药监局药审中心关于发布《上市后变更补充申请事项及受理时启动注册检验情形的说明表》的通知-2026/4/23
2026-04-24查看详情 > -
国家药监局关于发放药品电子注册证的公告（2022年 第83号）-2022/10/9
2022-11-14查看详情 > -
Q13 Continuous Manufacturing of Drug Substances and Drug Products(Final)-2323/03/01
2023-03-01查看详情 > -
关于公开征求《间充质干细胞防治移植物抗宿主病临床试验技术指导原则（征求意见稿）》意见的通知-2023/9/12
2023-09-14查看详情 > -
Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations-2025/1/7
2025-01-07查看详情 > -
Page: Linguistic review - Human-2025/2/10
2025-02-11查看详情 >
